# Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-antibody-drug-conjugate-early-results.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/antibody-drug-conjugate-shows-promising-early-results-in-phase-i-trial-in-sarcom-ea48b76a58bc597e
Kind: research · Impact: medium

## In brief

- An antibody-drug conjugate showed promising early results in a Phase I trial in patients with soft tissue sarcoma.
- The results were seen across several types of soft tissue sarcoma.
- The findings were presented at the 38th EORTC-NCI-AACR Symposium.

## Why it matters

Phase I trials mainly test safety and dosing, so these early signals suggest the approach may be worth pursuing in sarcoma, but efficacy is not yet established.

## Coverage

- [Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients](https://medicalxpress.com/news/2026-11-antibody-drug-conjugate-early-results.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: antibody-drug conjugate, sarcoma, phase I trial, oncology, clinical trial

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
